Sports Neurologist and Medical Director for the Center for Concussion Management at the University of Kansas Health System
Kansas City, MO
Joined August 2018
- Tweets560
- Following286
- Followers229
- Likes2.1K
Michael Rippee, MD retweeted
So these are occular motor exercises, used commonly in concussion & vestibular rehab
More precisely known as horizontal & vertical saccades
In this context, it appears he is using these as a form of a "visual warm-up" of sorts
Michael Rippee, MD retweeted
3 days. If you haven't registered yet—here's the short version:
Michael Wyand. Vishal Bansal. Alex Smith.
A live conversation on why ghrelin may be the key to treating concussion, what the Phase 2a data showed, and what Phase 2b is designed to prove. This is the conversation for anyone following this campaign closely.
📅 Thursday, June 18 · 11 AM PT / 2 PM ET
Reserve your spot: lu.ma/hzeeqjwl
OXE103 is investigational. Reg CF via StartEngine Primary LLC (FINRA/SIPC). Speculative, illiquid, high risk.
Michael Rippee, MD retweeted
We launched our StartEngine campaign to advance OXE103, a therapy for persistent #concussion symptoms.
What could be the first FDA-approved treatment.
startengine.com/offering/oxe…
Reg CF via StartEngine Primary, LLC (FINRA/SIPC). High Risk, Speculative, Illiquid.
Michael Rippee, MD retweeted
Hear NFL legend @AlexSmith_11 talk concussions on podcast with @oxeiabio CSO on Wednesday evening. Exploring possible new treatments to combat #Concussion Crisis. us06web.zoom.us/j/8700573071…
Michael Rippee, MD retweeted
Former NFL pro @AlexSmith_11 joining @oxeiabio CSO Vishal Bansal for podcast on #brain injury, #football concussions and hope for future treatment this Wednesday, January 7. us06web.zoom.us/j/8700573071…
Michael Rippee, MD retweeted
The concussion market forecasted to expand steadily, reaching $9.9 billion by 2029 according to @tbrc_info. Rise in awareness and management of #brain injuries are cited as major drivers. @oxeiabio featured as a projected major player in market growth. openpr.com/news/4328126/futu…
Michael Rippee, MD retweeted
Researchers from @Sunnybrook Research Institute and @ICESOntario reported in @BMJ_Open that people with #concussions were almost 50% more likely to be in a traffic crash and that the increased risk is highest in the first four weeks after their #TBI. bmjopen.bmj.com/content/15/1…
Michael Rippee, MD retweeted
“This is not just about one device. It’s about what happens when institutions grow comfortable living in their own ambiguity and hiding behind opacity.” trib.al/Bb5Zuzc
Michael Rippee, MD retweeted
Key finding: People w/ worse higher arterial stiffness & higher NfL showed the greatest cognitive deficits—especially in episodic & working memory. @TK_timoklein @J_C_MD_PhD @FannyElahi @NAASociety @VascAgeNet @Barnes_Lab @balkhaz @kevinmoncion @LBeishon @DrJMinhas
Michael Rippee, MD retweeted
Arterial stiffness moderates the link between NfL and cognition: The IGNITE study,” is now published! Proud to contribute to this project & publication w/ #IGNITE team & our @KUALZ team JillMorris EricVidoni JeffBurns
alz-journals.onlinelibrary.w…
Michael Rippee, MD retweeted
Concussive Brain Injury pathophysiology is evolving! Its more than "acute neuro-metabolic" cascade now. #ShaneBR @neuroayogi @MlPrinsPhD @BIRC_at_UCLA @UCLABrainSPORT @UCLANsgy @uclachildneuro @UCLANeurology @Neurotrauma
Learn more (50 days free access): authors.elsevier.com/a/1lTdB…
Michael Rippee, MD retweeted
The paper concludes preliminary data for the small non-randomized trial are nevertheless “compelling as a first-in-class treatment for postconcussion symptomatology.” Once we meet funding goals, we’ll be ready to conduct full scale multi-center, placebo controlled Phase 2b study
Michael Rippee, MD retweeted
Manuscript recently published by Neurotrauma Reports on pilot Phase IIa trial for treatment of #post-concussion symptoms with Oxeia’s drug, OXE103. The trial was conducted by lead investigator @MichaelRippee at Kansas University Medical Center,: bit.ly/3FLrpnv
Michael Rippee, MD retweeted
Oxeia CEO Michael Wyand talks with @editorNRTimes, exploring the gap in #TBI and #concussion treatment, the company’s promising results in its pilot Phase 2a study for #postconcussion treatment and the challenges of finding funding for the next trial. bit.ly/4jkKoCN
Michael Rippee, MD retweeted
Despite healthcare seeing incredible advancements over the past decade, the area of concussion and TBI treatment has seen little progress.
We speak to Dr. Michael Wyand, CEO of @oxeiabio about how its new treatment could transform concussion care.
nrtimes.co.uk/exploring-the-…
Michael Rippee, MD retweeted
Do you work with individuals who have experienced a concussion?
Please consider joining our study at the University of Kansas Medical Center! We're exploring what objective measures are commonly used in concussion management related to motor function!! If you have questions please contact Rebecca Bliss, PT, DPT, DHSc @ [email protected] Learn more and take survey: redcap.kumc.edu/surveys/?s=9…
Michael Rippee, MD retweeted
🔎 New Research Alert for Concussion Rehab Providers!
Psychometric Properties of Vestibular and Ocular Measures Used for Concussion Assessments: A Scoping Review (Barnes et al., 2024)
✅ This review mapped the landscape of clinical tools used to assess vestibular and ocular deficits after concussion.
✅ 52 studies were reviewed — most focusing on balance and VOR (vestibulo-ocular reflex) measures.
✅ Balance Error Scoring System (BESS) is the most studied but shows variable sensitivity and specificity — especially beyond the acute phase.
✅ Community Balance & Mobility Scale (CB&M) and Vestibular Ocular Motor Screening (VOMS) showed the most promise for clinical utility based on diagnostic accuracy and accessibility.
✅ Near Point of Convergence (NPC) testing also demonstrated positive psychometric properties for ocular assessment.
✅ There's a critical need for better psychometric validation and development of clinically feasible vestibular/ocular measures — especially for post-acute and chronic concussion care.
👉 Clinical Takeaways:
• Choose tests like VOMS, CB&M, and NPC that balance evidence, accessibility, and clinical relevance.
• Be cautious relying solely on BESS after the initial 72 hours post-injury.
• Incorporate multiple measures across domains (balance, VOR, ocular motor) for comprehensive concussion assessments.
• Push for more research — current tools still lack strong longitudinal reliability!
#ConcussionCare #VestibularRehab #OcularMotor #ClinicalPractice #RehabProfessionals #VestibularPT #ConcussionManagement pubmed.ncbi.nlm.nih.gov/3933…
Michael Rippee, MD retweeted
KU Medical Center and The University of Kansas Health System are hosting the 7th Annual Concussion Management Symposium on March 7th, 2025
Use this link to register or see more details:
eeds.com/portal_live_events.…
Michael Rippee, MD retweeted
Registration is open for Current Concepts in #Concussion Management 2025! We have a new date and location this year due to some construction. We have a great faculty this year. Looking forward to it! @KU_AHEC @KUMedCenter @KUSportsMed @KUHospital
eeds.com/live/570002
Michael Rippee, MD retweeted
Come join CISG and @SportsNeuroSoc in Milwaukee for 4 great days of programming around clinical advances and research in brain injury and brain health.
Visit concussioninsportgroup.com/s… to learn more and submit an abstract by Jan. 31st!
